Wealth Enhancement Advisory Services, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 5,118 shares of ALNY stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,118
Previous 14,404
64.47%
Holding current value
$1.74 Million
Previous $3.89 Million
57.11%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ALNY
# of Institutions
724Shares Held
111MCall Options Held
966KPut Options Held
853K-
Capital World Investors Los Angeles, CA16.7MShares$5.69 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.44 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.24 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.43 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.5 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $41.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...